摘要
目的了解入伍新兵人群中流行性脑脊髓膜炎(流脑)IgG抗体的流行分布情况,为今后预防提供科学依据。方法采用血清流行病学调查方法,用ELISA法对北京军区近4年来自7个省市的360名入伍新兵的血清进行流脑IgG抗体检测,统计分析其阳性率。结果各年间入伍新兵血清流脑IgG抗体历年无显著变化,阳性率在66.67%~96.67%,平均83.33%;抗体含量在6.23~26.47μg/mL,平均12.42μg/mL,地区间差异有统计学意义,湖北省(96.67%)、山东省(91.43%)和北京市(88.00%)较高,河南省(66.67%)和陕西省(72.50%)较低;入伍前工作与否人群,抗体阳性检出率差异无统计学意义(Х^2=0.12,P〉0.05)。结论入伍新兵人群中流脑IgG抗体阳性率为66.67%-96.67%,抗体含量在6.23—26.47μg/mL,并有地区差异,所以在新兵入伍期间应采取预防接种、健康教育等有效预防措施。
Objective To investigate the distribution of semgroup A epidemic cerehrospinal meningitis antibody IgG in recruits, provide scientific evidence for further prevention and control of the disease. Methods By using EIISA, semgroup A epidemic eerebrospinal meningitis antibody IgG serum samples of 360 recruits, who came from 7 provinces during the past four years, were detected, and the positive rate was analysed. Results There was no statistical difference in serum serogroup A epidemic cerebrospinal meningitis antibody IgG levels in each years, which ranged from 66.67% to 96.67% with a average rate of 83.33%, content of antibody ranged from 6.23 μg/mL to 26.47 μg/mL with an average content of 12.42μg/mL, regional difference existed. The higher level found in recruits from Hubei (96.67%) ,Shandong (91.43%)and Beijing (88.00%), and lower level from Henan (66.67%) and Shaanxi(72.50%). There was no significant correlation between the antibody IgG positive rate and education or occupation background of the recruits before their recruitment (Х^2 = 0.12, P 〉 0.05). Condusions The positive rate of semgroup A epidemic cembrospinal meningitis antibody IgG in recruits range from 66.67% to 96.67%, antibody level range from 6.23 μg/mL to 26.47 μg/mL, with a average content of 12.42μg/mL. The positive rate for antibody IgG varies in different provinces. It is necessary to give vaccination and education for the recruits to prevent serogroup A epidemic cerebmspinal meningitis spreading.
出处
《国际流行病学传染病学杂志》
CAS
2010年第3期166-169,共4页
International Journal of Epidemiology and Infectious Disease
关键词
脑膜炎
脑膜炎球菌性
抗体水平
流行病学调查
Meningitis, meningococcal
Antibody level
Epidemiologic investigation